Mobile

A study in people with Cystic Fibrosis (a rare hereditary pulmonary disease) to assess the long-term efficacy and safety of a combination of two experimental drugs

Mise à jour : Il y a 4 ans
Référence : EUCTR2013-000604-41

Femme et Homme

  • | Pays :
    • -
  • | Organes :
    • -
  • | Spécialités :
    • -

Extrait

To evaluate the long term safety and tolerability of lumacaftor in combination with ivacaftor in subjects with cystic fibrosis (CF) who are homozygous or heterozygous for the for the F508del-CFTR mutation

Critère d'inclusion

  • Cystic fibrosis in patients homozygous or heterozygous for the F508del-CFTR Mutation

Liens